Methylene blue shows paradoxical antioxidant activity at low doses via mitochondrial electron shuttling. Learn the proposed mechanisms, evidence limits, and saf
Methylene blue blocks the nitric oxide–cGMP vasodilation pathway, making it a rescue therapy in vasoplegic and septic shock. Evidence-based review.
Evidence-based review of methylene blue neuroprotection in Parkinson’s, ischemic stroke, and TBI animal models—mechanisms, key findings, and safety limits.
Explore the proposed mechanisms by which methylene blue may bypass mitochondrial Complex I and interact with Complex IV to support cellular energy production.
Methylene Blue inhibits MAO enzymes and has controlled trial data in bipolar disorder. What research shows — and the serious drug-interaction risks.
An honest review of methylene blue’s proposed cognitive mechanisms, its FDA-approved uses, the limits of current human evidence, and critical safety considerati
An honest look at methylene blue’s proposed mitochondrial and MAO-inhibiting mechanisms for brain fog and fatigue, with critical safety warnings for human use.
An evidence-based look at methylene blue’s antimicrobial and antiviral mechanisms, including photodynamic therapy research and SARS-CoV-2 laboratory findings.
An evidence-based look at methylene blue’s proposed anti-aging mechanisms — mitochondrial electron transport, cellular senescence, and ROS scavenging — with hon
Methylene blue is under clinical investigation as a tau aggregation inhibitor for Alzheimer’s disease. Here is what the evidence actually shows.